| Literature DB >> 35230242 |
Jinlong Wu1, Hui Zhang1, Ziyan Chen1, Ruijia Fu2, Hao Yang1, Hongfa Zeng1, Zhanbing Ren1.
Abstract
BACKGROUND: Virtual reality (VR) balance training is increasingly being pursued in biomedical research, specifically with respect to investigating balance ability with VR. However, existing systematic reviews have found inconsistent conclusions about the efficacy of VR in improving balance in Parkinson disease (PD) patients.Entities:
Keywords: Parkinson disease; VR; VR training; balance; meta-analysis; meta-regression; rehabilitation; serious games; systematic review; virtual reality
Year: 2022 PMID: 35230242 PMCID: PMC8924777 DOI: 10.2196/30882
Source DB: PubMed Journal: JMIR Serious Games Impact factor: 3.364
Figure 1The flow of literature search and study selection. RCT: randomized controlled trial.
Study characteristics.
| Reference | Participant characteristics | Intervention protocol | ||||||||
| Authors | Country, Language | Diagnostic criteria | Hoehn-Yahr classification | N, male/female | Age | Method | Session duration/frequency/period/# sessions/duration of VRa treatment per week | Platform | ||
| Chen et al [ | China, Chinese | Chinese Parkinson Diagnostic Criteria | EGb: 2.52 (SD 0.51); CGc: 2.57 (SD 0.50) | EG: 23, 14/9; CG: 23, 12/11 | EG: 62.09 (SD 6.11); CG: 64.65 (SD 5.06) | EG: VR training; CG: routine rehabilitation training | 50 min/5 times per wk/6 wk/30/250 min | BioFlex-FP posture control evaluation and training system | ||
| Cheng et al [ | China, Chinese | MDS-PDd | EG: 3.1 (SD 0.6); CG: 3.0 (SD 0.6) | EG: 20, 9/11; CG: 20, 8/12 | EG: 59.2 (SD 7.3); CG: 58.6 (SD 7.5) | EG: VR training+ routine rehabilitation training (40 min); CG: routine rehabilitation training | 20 min/2 times per wk/8 wk/16/40 min | Silverfit 3D motion capture analysis system | ||
| Sun et al [ | China, Chinese | Clinical diagnosis | Total: 1-4 | EG: 30, 19/11; CG: 30, 21/9 | EG: 61.43 (SD 7.34); CG: 62.54 (SD 6.98) | EG: VR training + strengthen muscle strength training (20 min); CG: routine rehabilitation training + medication | 20 min/5 times per wk/4 wk/20/100 min | Silverfit 3D motion capture analysis system | ||
| Lin et al [ | China, Chinese | Chinese Parkinson Diagnostic Criteria | Total: 2.5-4 | EG: 18, 12/6; CG: 15, 10/5 | EG: 61.4 (SD 8.2); CG: 62.1 (SD 6.3) | EG: VR training + medication; CG: routine rehabilitation training + medication | 30 min/5 times per wk/4 wk/20/150 min | Xbox (Microsoft Corp) | ||
| Liu et al [ | China, Chinese | Chinese Parkinson diagnostic criteria | Total: 3 | EG: 21, 11/10; CG: 21, 12/9 | EG: 60.9 (SD 7.20); CG: 63.9 (SD 5.82) | EG: VR training; CG: routine rehabilitation training | 20 min/5 times per wk/4 wk/20/150 min | Computer-assisted rehabilitation environment (CAREN) | ||
| Pompeu et al [ | Brazil, English | Clinical diagnosis | Total: 1-2 | Total: 32, 17/15 | Total: 67.4 (SD 8.1) | EG: VR training; CG: routine rehabilitation training | 30 min/2 times per wk/7 wk/14/60 min | Wii Fit (Nintendo Co Ltd) | ||
| Van et al [ | UK, English | UK-PDSBBe | Total: 2-3 | EG: 17, 12/5; CG: 16, 8/8 | EG: 66.3 (SD 6.39); CG: 68.8 (SD 9.68) | EG: VR training; CG: routine rehabilitation training | 60 min/2 times per wk/5 wk/10/120 min | Workstations consisted of a flat-panel LCD monitor connected to a PC containing a total of 6 commercially available, interactive dynamic balance exercises (Motek Medical) | ||
| Lee et al [ | Korea, English | Clinical diagnosis | NRf | EG: 10, 5/5; CG: 10, 5/5 | EG: 68.4 (SD 2.9); CG: 70.1 (SD 3.3) | EG: VR training + neurodevelopmental therapy (NR) + functional electrical stimulation therapy (NR); CG: routine rehabilitation training | 30 min/5 times per wk/6 wk/30/150 min | k-pop dance festival (Nintendo Inc) game for the Wii (Nintendo Inc) video game system | ||
| Shih et al [ | Taiwan, English | UK-PDSBB | EG: 1.6 (SD 0.84) ; CG: 1.4 (SD 0.52) | EG: 10, 9/1; CG: 10, 7/3 | EG: 67.5 (SD 9.96); CG: 68.8 (SD 9.67) | EG: VR training; CG: routine rehabilitation training | 50 min/2 times per wk/8 wk/16/100 min | Kinect sensor (Microsoft Corp) | ||
| Yang et al [ | Taiwan, English | UK-PDSBB | Total: 2-3 | EG: 11, 7/4; CG: 12, 7/5 | EG: 75.4 (SD 6.3); CG: 72.5 (SD 8.4) | EG: VR training; CG: routine rehabilitation training | 50 min/2 times per wk/6 wk/12/100 min | VR balance training system included a 22-inch all-in-one touchscreen computer (Micro-Star International Co Ltd) and a wireless balance board | ||
| Ozgonenel et al [ | Istanbul, English | Clinical diagnosis | Total: 1-3 | EG: 15, 10/5; CG: 18, 12/6 | EG: 64; CG: 65 | EG: VR training + routine rehabilitation training (NR); CG: balance rehabilitation training | 20 min/3 times per wk/5 wk/15/60 min | Xbox (Microsoft Corp) | ||
| Gandolfi et al [ | Italy, English | UK-PDSBB | Total: 1-3 | EG: 38, 23/15; CG: 38, 28/10 | EG: 67.45 (SD 7.18); CG: 69.84 (SD 9.41) | EG: VR training + balance rehabilitation training (NR); CG: sensory integration balance rehabilitation training | 50 min/3 times per wk/7 wk/21/150 min | Wii Fit gaming system and balance board (Nintendo Co Ltd) | ||
| Ribas et al [ | Brazil, English | UK-PDSBB | Total: 2-3 | EG: 10, 4/6; CG: 10, 4/6 | EG: 61.7. (SD 6.83); CG: 60.20 (SD 11.29) | EG: VR training; CG: routine rehabilitation training | 30 min/2 times per wk/12 wk/24/60 min | Wii Fit gaming system, and balance board (Nintendo Co Ltd) | ||
| Santos et al [ | US, English | UK-PDSBB | EG: 1.4 (SD 0.6); CG: 1.3 (SD 0.3) | EG: 13; CG: 14 | EG: 61.7 (SD 7.3); CG: 64.5 (SD 9.8) | EG: VR training; CG: routine rehabilitation training | 50 min/2 times per wk/8 wk/16/100 min | Wii Fit gaming system and balance board (Nintendo Co Ltd) | ||
| Feng et al [ | China, English | UK-PDSBB | EG: 3.03 (SD 0.55); CG: 2.97 (SD 2.66) | EG: 14, 8/7; CG: 14, 9/6 | EG: 67.47 (SD 4.79); CG: 66.93 (SD 4.64) | EG: VR training + medication; CG: routine rehabilitation training + medication | 45 min/5 times per wk/12 wk/60/225 min | NR | ||
| Tollár et al [ | UK, English | UK-PDSBB | EG: 2.3 (SD 0.48); CG: 2.4 (SD 0.51) | EG: 25, 12/13; CG: 25, 11/14 | EG: 70.0 (SD 4.69); CG: 70.6 (SD 4.10) | EG: VR training + medication; CG: routine rehabilitation training + medication | 60 min/5 times per wk/5 wk/25/300 min | EXEg used the following 3 visual feedback modules of the Xbox 360 core system (Kinect Adventures, Microsoft Corp) | ||
aVR: virtual reality.
bEG: experiment group.
cCG: control group.
dMDS-PD: Movement Disorder Society clinical diagnostic criteria for Parkinson disease.
eUK-PDSBB: United Kingdom Parkinson Disease Society Brain Bank criteria.
fNR: no report.
gEXE: exergame.
Study quality assessment of eligible studies.
| Author | Eligibility criteria | Randomization | Concealed allocation | Similar baseline | Blinding of participants | Blinding of instructors | Blinding of assessors | Retention >85% | Intent-to-treat analysis | Between-group comparison | Point measure and measures of variability | Sum score |
| Chen et al [ | 1a | 1 | 0b | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 |
| Cheng et al [ | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 5 |
| Sun et al [ | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 |
| Lin et al [ | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
| Liu et al [ | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 |
| Pompeu et al [ | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
| Van et al [ | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 7 |
| Lee et al [ | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 5 |
| Shih et al [ | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 8 |
| Yang et al [ | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |
| Ozgonenel et al [ | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 6 |
| Gandolfi et al [ | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
| Ribas et al [ | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 |
| Santos et al [ | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 7 |
| Feng et al [ | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 |
| Tollár et al [ | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 8 |
aExplicitly described and present in details.
bAbsent, inadequately described, or unclear.
Figure 2Forest plot for balance. SMD: standardized mean difference.
Figure 3Funnel plot for balance. SMD: standardized mean difference.
Results of the overall balance subgroup analyses on the influence of intervention method and intervention platform on virtual reality training in Parkinson disease.
| Independent training modality | SMDa | 95% CI |
| ||||
|
| |||||||
|
| Virtual reality mixed physical rehabilitation methods | 2.64 | 0.699 to 4.588 | 2.66 | 96.8 | 5 | <.001 |
|
| Virtual reality | 1.83 | 0.795 to 2.872 | 3.46 | 93.5 | 9 | <.001 |
|
| |||||||
|
| Virtual rehabilitation platform | 7.75 | 3.134 to 12.365 | 3.29 | 97.1 | 3 | <.001 |
|
| Commercial gaming virtual reality platform | 0.45 | –0.0.3 to 0.898 | 1.95 | 76.2 | 10 | <.001 |
aSMD: standardized mean difference.
bI2: heterogeneity between studies.
Results for the subgroup analyses on the effects of different categories of respective training volume on balance ability.
| Training volume | Coefficient | SE | 95% CI | 2-sided | |
| Training period | –0.0558 | 0.2075 | –0.4626 to 0.3509 | –0.27 | .79 |
| Training frequency | 1.9711 | 3.4458 | –4.7826 to 8.7248 | 0.57 | .57 |
| Number of sessions | 0.4613 | 1.3035 | –2.0935 to 3.0162 | 0.35 | .72 |
| Single session duration | –0.1145 | 0.3182 | –0.7381 to 0.5091 | 0.36 | .72 |
| Total duration per week | –2.1933 | 0.0572 | –0.1167 to 0.1077 | –0.08 | .94 |
Results for the subgroup analyses on the effects of different categories of respective training volume on overall balance.
| Independent training modality | SMDa | 95% CI |
| ||||||||||
|
| |||||||||||||
|
| 0-20 min | 6.446 | –1.098 to 13.990 | 1.67 (.094) | 98.7 | 2 | <.001 | ||||||
|
| 21-40 min | 1.050 | 0.122 to 1.979 | 2.22 (.027) | 89.4 | 5 | <.001 | ||||||
|
| 41-60 min | 1.644 | 0.378 to 2.910 | 2.54 (.011) | 93.6 | 6 | <.001 | ||||||
|
| |||||||||||||
|
| 1-3 sessions per week | 0.770 | –0.060 to 1.600 | 1.82 (.069) | 90.6 | 8 | <.001 | ||||||
|
| 4-6 sessions per week | 4.067 | 2.223 to 5.911 | 4.32 (<.001) | 96.1 | 6 | <.001 | ||||||
|
| |||||||||||||
|
| 3-5 weeks | 2.478 | 0.893 to 4.063 | 3.06 (.002) | 95.9 | 5 | <.001 | ||||||
|
| 6-8 weeks | 1.917 | 0.515 to 3.320 | 2.68 (.007) | 95.5 | 7 | <.001 | ||||||
|
| 9-12 weeks | 2.166 | 1.417 to 2.914 | 5.67 (.001) | 5.30 | 1 | <.001 | ||||||
|
| |||||||||||||
|
| 10-20 sessions | 0.844 | –0.210 to 1.898 | 1.57 (.117) | 91.4 | 6 | <.001 | ||||||
|
| 21-30 sessions | 2.638 | 1.003 to 4.272 | 3.16 (.002) | 96.5 | 5 | <.001 | ||||||
|
| >30 sessions | 4.405 | 1.102 to 7.707 | 2.61 (.009) | 95.0 | 2 | <.001 | ||||||
|
| |||||||||||||
|
| 0-100 min | 2.313 | 0.671 to 3.955 | 2.76 (.006) | 96.1 | 7 | <.001 | ||||||
|
| 101-200 min | 1.079 | 0.046 to 2.112 | 2.05 (.041) | 90.6 | 4 | <.001 | ||||||
|
| 201-300 min | 4.059 | 0.738 to 7.379 | 2.40 (.017) | 96.7 | 2 | <.001 | ||||||
aSMD: standardized mean difference.
bI: heterogeneity between studies.
cVR: virtual reality.